Search Within

Weinberg Fellows

  1. "2020"
Formats
  1. Meeting Abstract (162)
  2. Journal Article (125)
  3. Review (17)
  4. Editorial (9)
  5. Correspondence (4)
  6. Research Letter (4)
  7. Book Section (1)
  8. Guidelines (1)
Groups
  1. Department of Medicine (319)
  2. Hematology-Oncology Fellows (318)
  3. Solid Tumor Oncology Division (237)
  4. Hematologic Malignancies, Division of (166)
  5. GSK Faculty (161)
  6. Department of Pathology and Laboratory Medicine (126)

More Groups

People
  1. Pedram Razavi (38)
  2. Miguel-Angel Perales (28)
  3. Ahmet Zehir (27)
  4. David Solit (26)
  5. Sean Devlin (26)
  6. Marc Ladanyi (25)

More People

Years
  1. 2020 (323)
Publications
  1. Journal of Clinical Oncology (65)
  2. Blood (27)
  3. Cancer Research (19)
  4. Clinical Cancer Research (17)
  5. International Journal of Radiation Oncology, Biology, Physics (16)
  6. Journal for ImmunoTherapy of Cancer (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (74)
  2. American Association for Cancer Research (42)
  3. Elsevier Inc. (41)
  4. American Society of Hematology (35)
  5. Nature Publishing Group (25)
  6. Biomed Central Ltd (15)

More Publishers

Results (323)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic characterization of a RET inhibitor–resistant RET fusion–positive lung cancer by CSF cell-free DNA hybrid capture–based sequencing
    Journal Article

    Choudhury, N. J.; Yang, S. R.; Arcila, M.; Mohanty, A. S.; Boire, A.; Drilon, A.
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Outcomes of patients with hematologic malignancies and COVID-19 infection: A report from the ASH Research Collaborative Data Hub
    Meeting Abstract

    Wood, W. A.; Neuberg, D. S.; Thompson, J. C.; Tallman, M. S.; Sekeres, M. A.; Sehn, L. H.; Anderson, K.; Goldberg, A. D.; Pennell, N. A.; Niemeyer, C. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Venetoclax therapy for relapsed and treatment refractory AML: Clinical outcomes and molecular predictors
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J. L.; King, A. C.; Daniyan, A.; Famulare, C.; Cuello, B. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical outcomes of acute myeloid leukemia patients bridged to allogeneic stem cell transplant by venetoclax combination therapy
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; Barker, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Secondary graft-versus-host disease (GVHD) prophylaxis with oral proteasome inhibitor ixazomib is associated with low incidence of recurrent, late acute and chronic GVHD and facilitated calcineurin inhibitor taper within the first year post allogeneic stem cell transplantation
    Meeting Abstract

    Rodriguez, N.; Lee, J.; Flynn, L.; Murray, F.; Devlin, S.; Izquierdo, C. S.; Cho, C.; Dahi, P. B.; Giralt, S. A.; Sauter, C. S.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Favorable outcomes among patients with T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era
    Meeting Abstract

    Robin, E. T.; Drill, E.; Batlevi, C. L.; Caron, P.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; Joffe, E.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Characteristics and outcomes of newly diagnosed acute myeloid leukemia patients receiving venetoclax combinations vs other therapies: Results from the AML real world evidence (ARC) Initiative
    Meeting Abstract

    Pollyea, D. A.; Stahl, M.; Talati, C.; Asghari, H.; Lai, C.; Abedin, S.; Zeidner, J. F.; Muluneh, B.; Xavier, M.; Edwards, W.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Immunophenotypic lineage assessment by multiparameter flow cytometry provides more precise MDS prognosis
    Meeting Abstract

    Onyekwere, I.; Garcia, J. P.; Menghrajani, K.; Chan, A.; Famulare, C.; Patel, M. A.; Philip, J.; Tallman, M. S.; Klimek, V. M.; Levine, R. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Phase II study of pembrolizumab plus GVD as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Hancock, H.; Davey, T.; Sohail, S.; Santarosa, A.; Pomerantz, L.; Jarjies, C.; more...
    Blood (2020)

    Fulltext@MSK | Save